Interestingly, USP39 expression was negative correlated with NAFLD activity score in a cohort (GSE193084)20 of human NAFLD patients (Fig. 1d; Supplementary Table 1), we then focused on USP39 for further investigation. The gene discussed is USP39; the disease is metabolic dysfunction-associated steatotic liver disease.